¿Qué aporta prosigna en el tratamiento adyuvante de pacientes con cáncer de mama? - page 11

Validación prospectiva-retrospectiva del

Prosigna ROR en ABCSG08 y TRANSATAC

TRANSATAC

N = 1017 pac

TAM vs ANASTROZOL

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,2,3,4,5,6,7,8,9,10 12,13,14,15,16,17,18,19,20,21,...24